Duplication DiscountsDrug Discount340B in the Crosshairs: Pharma-Backed Ads Target Lawmakers Over Drug Discount SupportJohn Smith15 Mar 20253 min read
Duplication DiscountsDrug DiscountNebraska Becomes a Leader in Protecting 340B ContractEmily Johnson22 Apr 20254 min read
Duplication DiscountsDrug DiscountColorado's 340B Expansion Bill Faces Pushback from TaxpayerMichael Brown5 Jun 20252 min read
Duplication DiscountsDrug DiscountEthical Considerations in 340B Program ManagementSarah Davis30 Jul 20255 min read
Duplication DiscountsDrug DiscountMichigan's Legislative Action to Protect 340B Contract PharmaciesDavid Wilson12 Aug 20253 min read
Duplication DiscountsDrug DiscountThe Decline of U.S. Drugstores: What It Means for Underserved CommunitiesJessica Taylor19 Sep 20254 min read
Duplication DiscountsDrug DiscountThe Expanding Role of Pharmacy Technicians in HealthcareJames Anderson8 Feb 20252 min read
Duplication DiscountsDrug DiscountSpecialty Pharmacy vs. Retail Pharmacy: Key Differences and TrendsLaura Thomas27 Mar 20255 min read
Duplication DiscountsDrug DiscountPharmaceutical Companies Challenge 340B Rebate Rejections: What It Means for the Future of Drug PricingDaniel Martinez14 May 20253 min read
Duplication DiscountsDrug DiscountNew Study Exposes Geographic Inequities in 340B Program BenefitsSophia Garcia21 Jun 20254 min read
Duplication DiscountsDrug DiscountThe Role of Blockchain in 340B: Ensuring Transparency and Accuracy in Drug Supply ChainsChristopher Rodriguez3 Jul 20252 min read
Duplication DiscountsDrug DiscountWest Virginia's 340B Law Blocked: What It Means for Pharmacies and Drug PricingMegan Lee10 Aug 20255 min read